Correlation between NLR and Ferritin in COVID-19 Patients in ICU Dr. Kariadi Hospital
DOI:
https://doi.org/10.24293/ijcpml.v28i2.1760Keywords:
Neutrophils lymphocyte ratio, ferritin, COVID-19Abstract
COVID-19 infection is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Diabetes mellitus and heart disease comorbid have high morbidity and mortality. Increased neutrophils to lymphocyte ratio (NLR) and ferritin assist early screening of disease severity, especially in the Intensive Care Unit (ICU). Proving relationship between NLR and ferritin in COVID-19 patients in the ICU. The study was an analytical observational with a cross-sectional approach from July-October 2020 at the Laboratory of Clinical Pathology and Medical Records Dr. Kariadi Hospital Semarang. Pearson correlation method significance p<0.05, r 0.3<r<0.5, because normal normality. NLR and Ferritin mean value was 13.91 and 1675 with positive relationship correlation analysis (p=0.012,r=0.437),there was a correlation between NLR and ferritin in COVID-19 patients in the ICU. Increased NLR of COVID-19 patients due to infiltration of the innate and adaptive immune system in infected tissue,causes decreased circulating lymphocytes and disturbed proliferation caused by increased ferritin as an acute phase reactant protein. The study by Pastora JG,et al,2020,that serum ferritin concentrations were higher in non-survivor. In accordance with this, this increases NLR and ferritin in COVID-19 in the ICU. There is a moderate positive correlation between NLR and ferritin in COVID-19 patients at the ICU, Dr. Kariadi Hospital.
Downloads
References
World Health Oganization. Origin of SARS-CoV-2.2020. [cited at September 7, 2020]. Available at: WHO/2019-nCoV/FAQ/Virus_origin/2020.1
Kementerian Kesehatan Republik Indonesia. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19) REV-5. Jakarta: Kementrian Kesehatan RI;2020
Ge H, Wang X, Yuan X, Gong X, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis [Internet]. 2020 April 14 [cited at September 7,2020]; 39,6:1011-1019. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154215/ DOI:10.1007/s10096-020-03874-z
Yoon NB, Son C, Jung Um S. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann Lab Med [Internet]. 2013 Feb 21 [cited at September 7,2020]; 33,2: 105-10. Available from: https://pubmed.ncbi.nlm.nih.gov/23482854/ DOI:10.3343/alm.2013.33.2.105
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases [Internet].2020 August 1 [cited September 7,2020]; 71,15: 762–768. Available from: https://academic.oup.com/cid/article/71/15/762/5803306 doi.org/10.1093/cid/ciaa248
Liu Y, Du X, Chen J, Jin Y, Peng L,Wang HH, et al. Neutrophil to lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. Journal of Infection [Internet]. 2020 July [cited at September 7, 2020] 81,1: e6-e12. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0163445320302085 https://doi.org/10.1016/j.jinf.2020.04.002
Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science [Internet]. 2020 May 1 [cited at September 7, 2020]. 368: 473-474. Available from: https://science.sciencemag.org/content/368/6490/473.summary DOI: 10.1126/science.abb8925
Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol [Internet]. 2020 Jun [cited at September 7, 2020]. 215: 108427. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169933/ doi:10.1016/j.clim.2020.108427
Kernan KF, Joseph AC. Hyperferritinemia and inflammation. Int Immunol [Internet]. 2017 Nov 1 [cited at September 10, 2020]. 29,9 : 401-409. Available from: https://pubmed.ncbi.nlm.nih.gov/28541437/ DOI:10.1093/intimm/dxx031
Pastora JG, Weigand M, Kim J, Xian W, Strayer J, Palmer AF, et al. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?.Clin CHim Acta [Internet]. 2020 [cited at September 10, 2020]. 509: 249-251. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306200/ DOI:10.1016/j.cca.2020.06.033
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.